Royal Bank of Canada’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Royal Bank of Canada’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,825	Closed	-$834K	–	6942
2015 Q1	$834K	Sell	4,825 -140,103	-97%	-$20.6M	﹤0.01%	3044
2014 Q4	$16.7M	Buy	144,928 +56,568	+64%	+$6.85M	0.01%	950
2014 Q3	$13.8M	Sell	88,360 -47,457	-35%	-$6.88M	0.01%	1028
2014 Q2	$16.8M	Buy	135,817 +426	+0.3%	+$47.1K	0.01%	889
2014 Q1	$14M	Sell	135,391 -23,620	-15%	-$2.42M	0.01%	954
2013 Q4	$14.3M	Sell	159,011 -53,254	-25%	-$4.25M	0.01%	978
2013 Q3	$14.2M	Buy	212,265 +25,006	+13%	+$1.72M	0.01%	922
2013 Q2	$12.4M	Buy	+187,259	New	+$10.7M	0.01%	936

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's SLXP Position: Q2 2015 in Review

Royal Bank of Canada sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 4,825 shares — an estimated $834K sold.

Royal Bank of Canada first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $16.8M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Royal Bank of Canada reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Royal Bank of Canada sold 4,825 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $834K.
Royal Bank of Canada first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Royal Bank of Canada's SALIX PHARMACEUTICALS LTD DEL position peaked at $16.8M in Q2 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Royal Bank of Canada's 13F filing for Q2 2015, filed 14 Aug 2015.